Last reviewed · How we verify
HIGH Altitude CArdiovascular REsearch in the ANDES (HIGHCARE-A)
This study is aimed to assess the efficacy of combined treatment with two antihypertensive agents (telmisartan and nifedipine) in subjects with mild hypertension exposed to high altitude.
Details
| Lead sponsor | Istituto Auxologico Italiano |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 100 |
| Start date | 2012-05 |
| Completion | 2012-10 |
Conditions
- Hypertension
- High Altitude
Interventions
- Telmisartan
- Nifedipine
- placebo
Primary outcomes
- Effect of study treatment on 24 h ambulatory systolic blood pressure at high altitude — After 6 weeks of study treatment, during high altitude visit
Difference in 24 h ambulatory systolic BP at high altitude (Visit 4) between combination therapy group and placebo group
Countries
Peru